|
CAPZB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.177000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.810800E-01 |
| Normal-vs-Stage2 |
8.048400E-02 |
| Normal-vs-Stage3 |
6.575000E-01 |
| Normal-vs-Stage4 |
1.819620E-01 |
| Stage1-vs-Stage2 |
7.901700E-02 |
| Stage1-vs-Stage3 |
6.266800E-01 |
| Stage1-vs-Stage4 |
4.141800E-01 |
| Stage2-vs-Stage3 |
4.060800E-01 |
| Stage2-vs-Stage4 |
9.022800E-01 |
| Stage3-vs-Stage4 |
5.833800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.603200E-01 |
| Normal-vs-AfricanAmerican |
4.915800E-01 |
| Normal-vs-Asian |
6.118000E-01 |
| Caucasian-vs-AfricanAmerican |
5.948600E-01 |
| Caucasian-vs-Asian |
8.312000E-01 |
| AfricanAmerican-vs-Asian |
9.179800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.514800E-01 |
| Normal-vs-Female |
3.175600E-01 |
| Male-vs-Female |
9.405600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.117200E-01 |
| Normal-vs-Extreme_Weight |
7.363000E-01 |
| Normal-vs-Obese |
8.233400E-01 |
| Normal-vs-Extreme_Obese |
4.562500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.180600E-01 |
| Normal_Weight-vs-Obese |
5.620400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.091200E-01 |
| Extreme_Weight-vs-Obese |
6.154200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.116000E-01 |
| Obese-vs-Extreme_Obese |
1.702760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.713200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.016800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.639800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.543200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.033200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.611200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.613800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.047990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.427400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.858200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.720600E-01 |
| Normal-VS-Type2 PRCC |
1.095710E-02 |
| Normal-VS-KIRP CIMP |
8.013400E-01 |
| Normal-VS-Unclassified PRCC |
2.680200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.795880E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.169800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.610990E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.465050E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.484000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.329800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.618200E-01 |
| Normal-vs-N1 |
2.658600E-01 |
| Normal-vs-N2 |
6.524400E-01 |
| N0-vs-N1 |
5.841200E-01 |
| N0-vs-N2 |
9.516400E-01 |
| N1-vs-N2 |
8.512200E-01 |
|
|
